Loading clinical trials...

Post-operative Crohn's Endoscopic Recurrence Study | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Post-operative Crohn's Endoscopic Recurrence Study

Post-Operative Crohn's Disease Endoscopic Recurrence "POCER" Study: Endoscopic Guided Therapeutic Intervention & Determination of Cause

NCT00989560•University of Melbourne

View on ClinicalTrials.gov

Summary

This randomised, controlled study aims to evaluate the impact of endoscopic assessment, and adjustment of therapy, after surgery in patients with Crohn's disease. The primary endpoint is the severity of endoscopic recurrence. In addition, tissue will be collected for microbiological and immunological analysis.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•clinical diagnosis of Crohn's and proven history of disease
•patient undergone surgical resection with creation of a primary anastomosis

Exclusion Criteria

•endoscopically inaccessible anastomosis by standard colonoscopy
•presence of an end stoma
•pregnancy
•suspected perforation of the gastrointestinal tract
•presence of certain unsuitable comorbidities

Locations (1)

St Vincent's Hospital

Melbourne, Victoria, Australia

Key Dates

Start Date

August 1, 2009

Primary Completion Date

April 1, 2013

Completion Date

April 1, 2013

Last Updated

January 13, 2014

Enrollment

175

ACTUAL participants

Conditions

Crohn's Disease

Interventions

endoscopy

PROCEDURE

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITINGPHASE3

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184931

Crohn's Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Post-operative Crohn's Endoscopic Recurrence Study

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease